Biotech

All Articles

Takeda faucets brand-new head people oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of substantial management hirings, firings a...

Vertex, hammered by AATD once more, falls 2 resources on throw away heap

.Vertex's attempt to manage a rare hereditary illness has actually reached one more problem. The bio...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of personnel

.Vir Medical's second-quarter profits record wasn't except large updates. The business invited a tri...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism situation

.Galapagos has actually stopped briefly application in a trial of a BCMA-directed CAR-T cell therapy...

James Wilson leaving behind Penn to release 2 brand new biotechs

.After greater than 30 years, genetics therapy trailblazer James Wilson M.D., Ph.D., is actually lea...

3 biotechs make an effort to defeat the summer heat energy by losing team

.As biotechs attempt to transform a new page in August, a minimum of three companies have dropped st...

venBio lifts $528M for 5th lifestyle sciences VC fund

.Veteran venture capital firm venBio has actually lifted an additional half a billion dollars to pur...

Otsuka spends $800M for Jnana as well as its own clinical-stage PKU drug

.Otsuka Drug has actually picked up Boston-based Jnana Therapeutics for $800 million so the Oriental...

FibroGen lays off 75% people workers as asset fails 2 additional tests

.FibroGen is actually significantly reorganizing its service, giving up 75% of its own U.S. workers ...

Tracon winds down weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has decided to unwind operations full weeks after an injectable immune gate ...